Old Web
English
Sign In
Acemap
>
authorDetail
>
John Elliott Humphries
John Elliott Humphries
Controlled release
Medicine
Virology
Pharmacology
Pharmacokinetics
4
Papers
86
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Controlled release recombinant human interferon‐α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial
2011
Journal of Viral Hepatitis
I. Dzyublyk
T. Yegorova
L. Moroz
O. Popovych
I. Zaytsev
V. Miroshnichenko
A. Kromminga
M. M. Wilkes
E.-J. van Hoogdalem
John Elliott Humphries
Show All
Source
Cite
Save
Citations (8)
848 VIRAL KINETICS DURING TREATMENT WITH A CONTROLLED-RELEASE RECOMBINANT INTERFERON ALFA 2B IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS
2008
Journal of Hepatology
Eva Herrmann
Stefan Zeuzem
I. Dzyublyk
L. Moroz
I. Zaytsev
S. Martens
E.-J. van Hoogdalem
John Elliott Humphries
Show All
Source
Cite
Save
Citations (4)
Novel Controlled-Release Lemna-Derived IFN-α2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial
2008
Journal of Interferon and Cytokine Research
Leo G.J. de Leede
John Elliott Humphries
Anne C. Bechet
Ewoud J. Van Hoogdalem
Ruud Verrijk
David Gelvin Spencer
Show All
Source
Cite
Save
Citations (70)
565 Pharmacokinetics, safety and biomarkers in man after administration of locteron™, a once every two-weeks controlled release formulation of interferon-alpha
2006
Journal of Hepatology
A. Béchet
Ruud Verrijk
John Elliott Humphries
E. Venneker
L. de Leede
Show All
Source
Cite
Save
Citations (4)
1